We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Incidence and prevalence of psoriasis in Israel between 2011 and 2017.
- Authors
Schonmann, Y.; Ashcroft, D.M.; Iskandar, I.Y.K.; Parisi, R.; Sde‐Or, S.; Comaneshter, D.; Batat, E.; Shani, M.; Vinker, S.; Griffiths, C.E.M.; Cohen, A.D.
- Abstract
Background: Psoriasis is a common chronic inflammatory skin disease associated with a heavy burden of morbidity, disability and cost. The occurrence of the disease in Israel has not been previously investigated. Objectives: To provide standardized estimates of trends in psoriasis incidence, prevalence and mortality among patients in Israel between 2011 and 2017. Methods: Using electronic health records from Clalit Health Services, the largest nationwide public health provider in Israel, we conducted a population‐based study investigating trends in the annual incidence and prevalence of psoriasis between the years 2011 and 2017. We report age‐ and sex‐adjusted rates, using the standard European population as a reference. Results: We identified 71 094 incident psoriasis cases. The mean (SD) age of onset was 42.4 (21.0) years with a bimodal distribution, peaking in the early '30s and early '60s. Late‐onset psoriasis, occurring after 40 years of age, accounted for 51.1% of incident cases. The annual psoriasis incidence rate was constant throughout the study period (280/100 000 person‐years). Psoriasis prevalence rose from 2.5% in 2011 to 3.8% in 2017. Conclusions: Psoriasis prevalence is increasing in Israel, although its incidence is stable. Clinicians and policymakers should plan to address the growing demands in the clinical, economic and societal burden of psoriasis.
- Subjects
ISRAEL; PSORIASIS; ELECTRONIC health records; SKIN diseases; AGE of onset; DISEASE prevalence
- Publication
Journal of the European Academy of Dermatology & Venereology, 2019, Vol 33, Issue 11, p2075
- ISSN
0926-9959
- Publication type
Article
- DOI
10.1111/jdv.15762